Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-04-15
2011-12-27
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S169000, C514S170000
Reexamination Certificate
active
08084444
ABSTRACT:
Dermatitis can be effectively treated with the combined administration of dehydroepiandrosterone (DHEA) and a glucocorticoid. Systemic, topical and prepackaged DHEA-glucocorticoid embodiments are described.
REFERENCES:
patent: 4496556 (1985-01-01), Orentreich
patent: 6479058 (2002-11-01), McCadden
patent: 6552010 (2003-04-01), Schwartz et al.
patent: 2007/0015840 (2007-01-01), Dalko et al.
Wenninger et al. 1997, International Cosmetics Ingredient Dictionary and Handbook, pp. 1660-1662.
AHFS Drug Information 2001, American Society of Health-System Pharmacists, Inc. 2001 Schimmer & Parker, Bethesda, MD.
Drake, Lynn A., et al., Guidelines of care for contact dermatitis, J Am Acad Dermatol. 1995; 32:109-13.
Bird, C.E., et al, Dehydroepiandrosterone: Kinetics of metabolism in normal men and women, J Clin Endocrinol Metab. 1978;47:818-822.
Brazzini, B., Pimpinelli, N., New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use, Am J Clin Dermatol. 2002; 3(1):47-58.
Crawford, G.H., McGovern, T.W., Poison ivy, N Engl J Med. Nov. 21, 2002, 347(21):1723.
Gallegos, A.J., Berliner, D.L., Transformation and conjugation of dehydroepiandrosterone by human skin. J Clin Endocrinol Metab. 1967;27:1214-8.
Geracioti, T.D., DHEA supplementation of systemic glucocorticoids, International J Dermatol. 2005, in press.
Green, C., et al., Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use, Br J Dermatol. Jan. 2005;152(1):130-41.
Guin, J.D., Complications of topical hydrocortisone, Am Acad Dermatol. Apr. 1981;4(4):417-22.
Guin, J.D., Treatment of toxicodendron dermatitis (poison ivy and poison oak), Skin Therapy Letter, Apr. 2001;6(7):3-6.
Juckett, G., Plant dermatitis: Possible culprits go far beyond poison ivy. Postgrad Med. Sep. 1996; 100(3):159-171.
Lee, S.S., Topical steroids, International J Dermatology. Dec. 1981; 20(10):632-41.
Leung, D.Y.M., et al., New insights into atopic dermatitis, J Clin Invest. 2004;113(5):651-57.
Meding, B., Jarvholm, B., Hand eczema in Swedish adults—changes in prevalence between 1983 and 1996, J Invest Dermatol, Apr. 2002;118(4):719-23.
Pearce, D.J., et al., Class I topical corticosteroid use by psoriasis patients in an academic practice, J Dermatolog Treat. 1004;15:235-8.
Rapaport, M.J., Lebwohl, M., Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome, Clinics in Dermatology. 2003;21:201-214.
Resnick, S.D., Poison-ivy and poison-oak dermatitis, Clinic in Dermatology. Apr.-Jun. 1986: 4(2):208-212.
Rosenfeld, B.J., et al., 24-hour secretory pattern of dehydroisonandrosterone and dehydroisoandrosterone sulfate, J Clin Endocrinol Metab. 1975;40(5):850-855.
Schimmer, B.P., Parker, K.L., Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones, In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's The Pharmacologic Basis of Therapeutics, 10thedition. McGraw-Hill Medical Publishing Co., NY, NY, 2001, pp. 1649-1677.
Van Coevorden, A.M., et al., Overview of studies of treatments for hand eczema—the EDEN hand eczema survey, British Journal of Dermatology. 2004;151:446-451.
Van Vollenhoven, R.F., et al., Dehydroepiandrosterone in systemic lupus erythematosus: results of a double-blind, placebo-controlled, randomized clinical trial, Arthritis Rheum, Dec. 1995; 38(12):1826-1831.
Frost Brown Todd LLC
Jean-Louis Samira
Padmanabhan Sreeni
RxDino, LLC
LandOfFree
Treatment of dermatitis with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of dermatitis with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of dermatitis with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4263004